tiprankstipranks
MBX Biosciences Reports Q3 2024 Financial Progress
PremiumCompany AnnouncementsMBX Biosciences Reports Q3 2024 Financial Progress
4M ago
MBX Biosciences reports Q3 EPS ($2.78), consensus ($2.72)
Premium
The Fly
MBX Biosciences reports Q3 EPS ($2.78), consensus ($2.72)
4M ago
MBX Biosciences sees cash runway into mid-2027
Premium
The Fly
MBX Biosciences sees cash runway into mid-2027
4M ago
MBX Biosciences initiated with a Buy at Guggenheim
PremiumThe FlyMBX Biosciences initiated with a Buy at Guggenheim
5M ago
Opening Day: StandardAero surges in market debut
Premium
The Fly
Opening Day: StandardAero surges in market debut
5M ago
MBX Biosciences presents MBX 2109 Phase 2 Avail trial rationale, design
Premium
The Fly
MBX Biosciences presents MBX 2109 Phase 2 Avail trial rationale, design
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100